Kronic screening method developed
A Christchurch laboratory is the first in New Zealand to develop a screening method for Kronic, a synthetic cannabis product.
Canterbury Health Laboratories last year developed the testing method, which detects the presence of synthetic drugs in urine.
The lab gained accreditation for the testing last week.
Quality and business development manager Kevin Taylor said the firm was the first in the country to gain accreditation and the first to be able to test for synthetic drugs.
"It means companies using CHL's workplace drug-testing service will now be able to test for these substances and, depending on their individual health and safety policy, be able to use this information accordingly.''
Synthetic drugs, including Kronic, were banned in August after emergency departments across the country reported increasing numbers of people were being treated for side-effects as a result of its use.